Showing results (31-40 of 122) with videos related to
Sort By:
Pageof 13
BJC Reports|November 8, 2024
The natural history of neurolymphomatosisElizabeth Xu, Quan Ho, Ashley Liu, et al.Plos One|September 20, 2018
Tubulin's response to external electric fields by molecular dynamics simulationsJoshua J Timmons, Jordane Preto, Jack A Tuszynski, et al.Seminars in Oncology|September 13, 2014
Post Hoc analyses of intention-to-treat population in phase III comparison of NovoTTF-100A™ system versus best physician's choice chemotherapyAndrew A Kanner, Eric T Wong, John L Villano, et al.Neuro-Oncology Advances|May 16, 2025
Effects of craniectomy defect on tumor-treating fieldsEdwin Lok, Bryant Chang, Rafael Vega, et al.Journal of Neuro-Oncology|January 29, 2020
Finite element analysis of Tumor Treating Fields in a patient with posterior fossa glioblastomaEdwin Lok, Pyay San, Olivia Liang, et al.Cancer Medicine|June 17, 2014
The natural history of intravascular lymphomatosisEkokobe Fonkem, Edwin Lok, David Robison, et al.Cancer Medicine|May 26, 2017
Analysis of physical characteristics of Tumor Treating Fields for human glioblastomaEdwin Lok, Pyay San, Van Hua, et al.Melanoma Research|January 28, 2014
Melanoma brain metastasis globally reconfigures chemokine and cytokine profiles in patient cerebrospinal fluidEdwin Lok, Amy S Chung, Kenneth D Swanson, et al.Neurosci|May 27, 2026
PART as a Negative Outcome Modifier of Glioblastoma Treatment, Case ReportRoss Terada, Jennifer Dailey, Sherry Yan, et al.Clinical Lymphoma & Myeloma|February 28, 2007
Matrix metalloprotease-9 in cerebrospinal fluid correlates with disease activity in lymphomatous meningitisEric T Wong, Diana Lee, Angela Tam, et al.Pageof 13